AB
EWTX icon

Amalgamated Bank’s Edgewise Therapeutics EWTX Stock Holding History

Amalgamated Bank’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,120
Closed -$53K – 2023
2025
Q4 		$53K Sell
2,120
-401
-16% -$8.05K ﹤0.01% 1823
2025
Q3 		$41K Hold
2,521
– – ﹤0.01% 1903
2025
Q2 		$33K Hold
2,521
– – ﹤0.01% 1948
2025
Q1 		$55K Buy
2,521
+9
+0.4% +$236 ﹤0.01% 1786
2024
Q4 		$67K Hold
2,512
– – ﹤0.01% 1774
2024
Q3 		$67K Hold
2,512
– – ﹤0.01% 1772
2024
Q2 		$45K Buy
2,512
+565
+29% +$9.86K ﹤0.01% 1876
2024
Q1 		$36K Sell
1,947
-1,600
-45% -$25.4K ﹤0.01% 1944
2023
Q4 		$39K Sell
3,547
-396
-10% -$2.78K ﹤0.01% 2354
2023
Q3 		$23K Hold
3,943
– – ﹤0.01% 2579
2023
Q2 		$31K Hold
3,943
– – ﹤0.01% 2511
2023
Q1 		$26K Sell
3,943
-993
-20% -$9.2K ﹤0.01% 2547
2022
Q4 		$44K Buy
4,936
+782
+19% +$7.33K ﹤0.01% 2477
2022
Q3 		$41K Hold
4,154
– – ﹤0.01% 2545
2022
Q2 		$33K Sell
4,154
-2,145
-34% -$16.2K ﹤0.01% 2663
2022
Q1 		$61K Buy
+6,299
New +$81.1K ﹤0.01% 2373

Other funds holding EWTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Amalgamated Bank's EWTX Position: Q1 2026 in Review

Amalgamated Bank sold out of Edgewise Therapeutics (EWTX) in Q1 2026, closing a stake of 2,120 shares — an estimated $53K sold.

Amalgamated Bank first reported a position in EWTX in Q1 2022 and held it in 16 quarters. The position peaked at $67K in Q4 2024. 214 funds tracked by Wall St. Rank hold EWTX as of Q1 2026.

  • Amalgamated Bank reported no remaining Edgewise Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 2,120 Edgewise Therapeutics shares in Q1 2026, an estimated $53K.
  • Amalgamated Bank first reported a position in Edgewise Therapeutics in Q1 2022 and held it in 16 quarters.
  • Amalgamated Bank's Edgewise Therapeutics position peaked at $67K in Q4 2024.
  • 214 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.